Kodiak Sciences Inc. (KOD)
NASDAQ: KOD · Real-Time Price · USD
14.92
+0.04 (0.27%)
At close: Oct 16, 2025, 4:00 PM EDT
15.00
+0.08 (0.54%)
After-hours: Oct 16, 2025, 7:11 PM EDT
Kodiak Sciences Market Cap
Kodiak Sciences has a market cap or net worth of $786.34 million as of October 16, 2025. Its market cap has increased by 474.01% in one year.
Market Cap
786.34M
Enterprise Value
747.39M
1-Year Change
474.01%
Ranking
Category
Stock Price
$14.92
Market Cap Chart
Since October 4, 2018, Kodiak Sciences's market cap has increased from $357.63M to $786.34M, an increase of 119.87%. That is a compound annual growth rate of 11.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2025 | 784.23M | 50.12% |
| Dec 31, 2024 | 522.39M | 228.65% |
| Dec 29, 2023 | 158.95M | -57.33% |
| Dec 30, 2022 | 372.50M | -91.44% |
| Dec 31, 2021 | 4.35B | -41.22% |
| Dec 31, 2020 | 7.40B | 134.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 742.04B |
| Johnson & Johnson | 460.40B |
| AbbVie | 399.63B |
| UnitedHealth Group | 327.08B |
| AstraZeneca | 262.65B |
| Novartis AG | 252.43B |
| Novo Nordisk | 251.88B |
| Abbott Laboratories | 225.30B |